CliniGA CRO

CliniGA CRO Blog

Completing CRO exit with operational handover acceptance

Receiving folders at the end of a CRO agreement does not demonstrate that the trial can be taken over.

Representative research photograph: Completing CRO exit with operational handover acceptance
Photo: U.S. Air Force photo by Airman 1st Class Joseph Barron · License: Public domain · Cropped and resized.
Published
Updated

Receiving folders at the end of a CRO agreement does not demonstrate that the trial can be taken over. Open decisions, system access, supplier relationships and unfinished notifications also need transfer. Sponsors should treat exit as controlled transition of continuing responsibilities rather than commercial closure alone.

Decision framework

Define handover scope in terms of activities, records and decisions. Verify usability of transferred files and the locations of retained records. Identify new owners of open work and the transition period between teams. Authorised contract owners should assess how disputed fees and necessary record access will be managed.

Worked example

For example, the outgoing CRO supplies a query list without explaining which responses await investigator assessment. The incoming team risks restarting work unnecessarily. Handover review reconciles status meanings, earlier decisions and next actions through sampled examples. Matching file counts alone does not become the criterion for accepting the transition.

Implementation checks

  • Show record ownership, location, access method and necessary continuing action together in the handover inventory.
  • Use a worked activity to test whether the new team can actually continue critical work with the information provided.
  • State clearly which team receives new records and questions arising while the transition remains in progress.

Acceptance and boundaries

Accept handover when new owners can continue essential trial workflows. Plan the scope of explanatory support if the former provider may still be needed. Do not assume that retention, confidentiality or participant-protection obligations end simply because the commercial relationship has finished.

Frequently asked questions

Is providing all data in one file sufficient?
No. The meaning of the information, open statuses and its operational context also need transfer.
What happens if a problem appears after acceptance?
Define clarification, correction and escalation routes prospectively in the agreement and transition plan.

Sources

  1. EMA — ICH E6 good clinical practice
  2. WHO — Guidance for best practices for clinical trials